Vaccine Adjuvant
Vesiculated alpha-tocopheryl succinate enhances effect of dendritic cell vaccines
Published in Vaccine Weekly, February 15th, 2006
According to recent research from the United States, "Alpha tocopheryl succinate (alpha-TOS) is a non-toxic vitamin E analog under study for its anti-cancer properties. In an earlier study, we showed that alpha-TOS, when used in combination with non-matured dendritic cells (nmDC) to treat pre-established tumors, acts as an effective adjuvant. In this study, we have used vesiculated alpha-TOS (V alpha-TOS), a more soluble form of alpha-TOS that is relevant for clinical use, in combination with dendritic cells to treat pre-established murine tumors."
"We...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-02-15)
More Articles from Vaccine Weekly
- Alzheimer Disease Vaccine
Study examined effects of epitopes and adjuvants on anti-Alzheimer DNA vaccine - Avian Influenza Vaccine
Research quantifies vaccination effect on transmission of avian influenza in chickens - Diabetes Vaccine
DNA vaccine prevents diabetes through enhanced beta cell proliferation - Herpes Vaccine
CpG ODN enhances HSV DNA vaccine efficacy against genital herpes - Addiction Medicine
Review examines future advances in addiction treatment - Adenovirus Vector
Scientists generated rabbit VH domain antibody specific to c-Met and adenoviral knob protein - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
